---
layout: post
title: "Prospective Grant of Exclusive License, Inter-Institutional Agreement-Institution Lead: Development of Zika Virus Strains for Use in Oncolytic Therapy"
date: 2026-02-04 21:49:25 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2025-18692
original_published: 2025-09-26 00:00:00 +0000
significance: 8.00
---

# Prospective Grant of Exclusive License, Inter-Institutional Agreement-Institution Lead: Development of Zika Virus Strains for Use in Oncolytic Therapy

**Published:** February 04, 2026 21:49 UTC
**Source:** Federal Register
**Original Published:** September 26, 2025 00:00 UTC
**Document Number:** 2025-18692

## Summary

The National Institute of Allergy and Infectious Diseases, an institute of the National Institutes of Health, Department of Health and Human Services, Department of Health and Human Services, is contemplating the grant of an exclusive patent license to Advocate Aurora Research Institute, located in Milwaukee, Wisconsin, to practice the inventions embodied in the patent applications listed in the Supplementary Information section of this notice.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2025/09/26/2025-18692/prospective-grant-of-exclusive-license-inter-institutional-agreement-institution-lead-development-of)
- API: https://www.federalregister.gov/api/v1/documents/2025-18692

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
